Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04462809
Title Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma (TALAMESO)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hospices Civils de Lyon
Indications

malignant mesothelioma

Therapies

Talazoparib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.